News
Video
Author(s):
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
The public may not know much about pharmacy compounding, and physicians who don’t know about it may be missing out on treatments for their patients. Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding, offers his advice to phyisicians and other clinicians about building a relationship with a compounding pharmacist.